PREDISSOCIATION DYNAMICS OF HCP: ROTATIONAL DISTRIBUTION OF PRODUCT CP RADICAL

M. Namai,H. Ishikawa,T. Sasaki,N. Mikami

Abstract:Author Institution: Graduate School of Science, Tohoku University; Department of Chemistry, Graduate School of Science, Tohoku University

What problem does this paper attempt to address?

GPER Acts Through the cAMP/Epac/JNK/AP-1 Pathway to Induce Transcription of Alpha 2C Adrenoceptor in Human Microvascular Smooth Muscle Cells

Manal Fardoun,Suzanne A Nasser,Ahmed F El-Yazbi,Ali H Eid

DOI: https://doi.org/10.1097/FJC.0000000000001489

2023-12-01

Abstract:Raynaud's phenomenon, which results from exaggerated cold-induced vasoconstriction, is more prevalent in females than males. We previously showed that estrogen increases the expression of alpha 2C-adrenoceptors (α 2C -AR), the sole mediator of cold-induced vasoconstriction. This effect of estrogen is reproduced by the cell-impermeable form of the hormone (E 2 :bovine serum albumin [BSA]), suggesting a role of the membrane estrogen receptor, G-protein-coupled estrogen receptor [GPER], in E 2 -induced α 2C -AR expression. We also previously reported that E 2 upregulates α 2C -AR in microvascular smooth muscle cells (VSMCs) via the cAMP/Epac/Rap/JNK/AP-1 pathway, and that E 2 :BSA elevates cAMP levels. We, therefore, hypothesized that E 2 uses GPER to upregulate α 2C -AR through the cAMP/Epac/JNK/AP-1 pathway. Our results show that G15, a selective GPER antagonist, attenuates the E 2 -induced increase in α 2C -AR transcription. G-1, a selective GPER agonist, induced α 2C -AR transcription, which was concomitant with elevated cAMP levels and JNK activation. Pretreatment with ESI09, an Epac inhibitor, abolished G-1-induced α 2C -AR upregulation and JNK activation. Moreover, pretreatment with SP600125, a JNK-specific inhibitor, but not H89, a PKA-specific inhibitor, abolished G-1-induced α 2C -AR upregulation. In addition, transient transfection of an Epac dominant negative mutant (Epac-DN) attenuated G-1-induced activation of the α 2C -AR promoter. This inhibitory effect of Epac-DN on the α 2C -AR promoter was overridden by the cotransfection of constitutively active JNK mutant. Furthermore, mutation of AP-1 site in the α 2C -AR promoter abrogated G1-induced expression. Collectively, these results indicate that GPER upregulates α 2C -AR through the cAMP/EPAC/JNK/AP-1 pathway. These findings unravel GPER as a new mediator of cold-induced vasoconstriction, and present it as a potential target for treating Raynaud's phenomenon in estrogen-replete females.
The Role of G Protein-Coupled Estrogen Receptor (GPER) in Vascular Pathology and Physiology

Fujie Xu,Jipeng Ma,Xiaowu Wang,Xiaoya Wang,Weiyi Fang,Jingwei Sun,Zilin Li,Jincheng Liu

DOI: https://doi.org/10.3390/biom13091410

IF: 6.064

2023-09-20

Biomolecules

Abstract:Objective: Estrogen is indispensable in health and disease and mainly functions through its receptors. The protection of the cardiovascular system by estrogen and its receptors has been recognized for decades. Numerous studies with a focus on estrogen and its receptor system have been conducted to elucidate the underlying mechanism. Although nuclear estrogen receptors, including estrogen receptor-α and estrogen receptor-β, have been shown to be classical receptors that mediate genomic effects, studies now show that GPER mainly mediates rapid signaling events as well as transcriptional regulation via binding to estrogen as a membrane receptor. With the discovery of selective synthetic ligands for GPER and the utilization of GPER knockout mice, significant progress has been made in understanding the function of GPER. In this review, the tissue and cellular localizations, endogenous and exogenous ligands, and signaling pathways of GPER are systematically summarized in diverse physiological and diseased conditions. This article further emphasizes the role of GPER in vascular pathology and physiology, focusing on the latest research progress and evidence of GPER as a promising therapeutic target in hypertension, pulmonary hypertension, and atherosclerosis. Thus, selective regulation of GPER by its agonists and antagonists have the potential to be used in clinical practice for treating such diseases.

biochemistry & molecular biology
Role of GPER in estrogen-dependent nitric oxide formation and vasodilation

Natalie C Fredette,Matthias R Meyer,Eric R Prossnitz

DOI: https://doi.org/10.1016/j.jsbmb.2017.05.006

Abstract:Estrogens are potent regulators of vasomotor tone, yet underlying receptor- and ligand-specific signaling pathways remain poorly characterized. The primary physiological estrogen 17β-estradiol (E2), a non-selective agonist of classical nuclear estrogen receptors (ERα and ERβ) as well as the G protein-coupled estrogen receptor (GPER), stimulates formation of the vasodilator nitric oxide (NO) in endothelial cells. Here, we studied the contribution of GPER signaling in E2-dependent activation of endothelial NO formation and subsequent vasodilation. Employing E2 and the GPER-selective agonist G-1, we investigated eNOS phosphorylation and NO formation in human endothelial cells, and endothelium-dependent vasodilation in the aortae of wild-type and Gper-deficient mice. Both E2 and G-1 induced phosphorylation of eNOS at the activation site Ser1177 to similar extents. Endothelial NO production to E2 was comparable to that of G-1, and was substantially reduced after pharmacological inhibition of GPER. Similarly, the clinically used ER-targeting drugs 4OH-tamoxifen, raloxifene, and ICI182,780 (faslodex, fulvestrant™) induced NO formation in part via GPER. We identified c-Src, EGFR, PI3K and ERK signaling pathways to be involved in GPER-dependent NO formation. In line with activation of NO formation in cells, E2 and G-1 induced equally potent vasodilation in the aorta of wild-type mice. Gper deletion completely abrogated the vasodilator response to G-1, while reducing the response to E2 by ∼50%. These findings indicate that a substantial portion of E2-induced endothelium-dependent vasodilation and NO formation is mediated by GPER. Thus, selective targeting of vascular GPER may be a suitable approach to activate the endothelial NO pathway, possibly leading to reduced vasomotor tone and inhibition of atherosclerotic vascular disease.
Ligand recognition, unconventional activation, and G protein coupling of the prostaglandin E<sub>2</sub> receptor EP2 subtype

Changxiu Qu,Chunyou Mao,Peng Xiao,Qingya Shen,Ya-Ni Zhong,Fan Yang,Dan-Dan Shen,Xiaona Tao,Huibing Zhang,Xu Yan,Ru-Jia Zhao,Junyan He,Ying Guan,Chao Zhang,Guihua Hou,Peng-Ju Zhang,Guige Hou,Zijian Li,Xiao Yu,Ren-Jie Chai,You-Fei Guan,Jin-Peng Sun,Yan Zhang

DOI: https://doi.org/10.1126/sciadv.abf1268

IF: 13.6

2021-01-01

Science Advances

Abstract:Selective modulation of the heterotrimeric G protein alpha S subunit-coupled prostaglandin E-2 (PGE(2)) receptor EP2 subtype is a promising therapeutic strategy for osteoporosis, ocular hypertension, neurodegenerative diseases, and cardiovascular disorders. Here, we report the cryo-electron microscopy structure of the EP2-G(s) complex with its endogenous agonist PGE(2) and two synthesized agonists, taprenepag and evatanepag (CP-533536). These structures revealed distinct features of EP2 within the EP receptor family in terms of its unconventional receptor activation and G protein coupling mechanisms, including activation in the absence of a typical W-6.48 "toggle switch" and coupling to G(s) via helix 8. Moreover, inspection of the agonist-bound EP2 structures uncovered key motifs governing ligand selectivity. Our study provides important knowledge for agonist recognition and activation mechanisms of EP2 and will facilitate the rational design of drugs targeting the PGE(2) signaling system.
Activation of G Protein-Coupled Estrogen Receptor (GPER) Negatively Modulates Cardiac Excitation–Contraction Coupling (ECC) through the PI3K/NOS/NO Pathway

Leandro A. Diaz-Zegarra,María S. Espejo,Alejandro M. Ibañez,Mónica E. Rando,Lucia E. Pagola,Verónica C. De Giusti,Ernesto A. Aiello

DOI: https://doi.org/10.3390/ijms25168993

IF: 5.6

2024-08-19

International Journal of Molecular Sciences

Abstract:The G-protein-coupled estrogen receptor (GPER) has been described to exert several cardioprotective effects. However, the exact mechanism involved in cardiac protection remains unclear. The aim of this study is to investigate the role of GPER activation on excitation–contraction coupling (ECC) and the possibility that such effect participates in cardioprotection. The cardiac myocytes of male Wistar rats were isolated with a digestive buffer and loaded with Fura-2-AM for the measurement of intracellular calcium transient (CaT). Sarcomere shortening (SS) and L-type calcium current (ICaL) were also registered. The confocal technique was used to measure nitric oxide (NO) production in cells loaded with DAF-FM-diacetate. Cardiac myocytes exposed to 17-β-estradiol (E2, 10 nM) or G-1 (1 μM) for fifteen minutes decreased CaT, SS, and ICaL. These effects were prevented using G-36 (antagonist of GPER, 1 μM), L-Name (NO synthase -NOS- inhibitor, 100 nM), or wortmannin (phosphoinositide-3-kinase -PI3K- inhibitor, 100 nM). Moreover, G1 increased NO production, and this effect was abolished in the presence of wortmannin. We concluded that the selective activation of GPER with E2 or G1 in the isolated cardiac myocytes of male rats induced a negative inotropic effect due to the reduction in ICaL and the decrease in CaT. Finally, the pathway that we proposed to be implicated in these effects is PI3K-NOS-NO.

biochemistry & molecular biology,chemistry, multidisciplinary
17β-Estradiol inhibits oleic acid-induced rat VSMC Proliferation and migration by restoring PGC-1α expression

Xiaohong Jiang,Yan Zhang,Dongxia Hou,Lingyun Zhu,Wei Xu,Li Ding,Xiaoqiang Qi,Guoxun Sun,Chang Liu,Junfeng Zhang,Ke Zen,Yang Xiang,Chen-Yu Zhang

DOI: https://doi.org/10.1016/j.mce.2009.09.018

IF: 4.369

2010-01-01

Molecular and Cellular Endocrinology

Abstract:Estrogen shows a vasoprotective role through inhibiting the proliferation and migration of vascular smooth muscle cells (VSMCs). The mechanism underlying the effect of estrogen, however, is not completely understood. Here, we explored the role of peroxisome proliferator-activated receptor-gamma (PPARγ) coactivator-1alpha (PGC-1α) in estrogen-mediated vasoprotection. Firstly, we showed that oleic acid (OA) decreased PGC-1α expression while stimulating VSMC proliferation and migration. In contrast, administration of VSMCs with 17β-estradiol (E2, 1 or 10nM) significantly restored OA-decreased PGC-1α expression, treatment with 10nM E2 almost completely abolished OA-induced VSMC proliferation and migration. Secondly, by using PGC-1α siRNA, the inhibitory effect of E2 on VSMC growth is strongly reduced via suppressing PGC-1α expression, indicating that E2 may exert its role through restoring PGC-1α. Finally, E2 (10nM) treatment inhibits OA-induced extracellular signal-regulated kinase 1/2 (ERK1/2) phosphorylation, however, suppression of PGC-1α expression abolishes this inhibitory effect of E2. Our findings demonstrate for the first time that in OA-stimulated rat VSMCs, treatment with E2 (1 or 10nM) diminishes VSMC proliferation and migration via restoring OA-decreased PGC-1α expression. This observation offers a novel molecular basis of the vasoprotective effect of estrogen.
G-protein Coupled Estrogen Receptor (GPER/GPR30) and Women's Health

Mi-Jin Kim,Tae-Hee Kim,Hae-Hyeog Lee

DOI: https://doi.org/10.6118/jmm.2015.21.2.79

Abstract:Estrogen - the female sexual hormone playing the most important role - plays a physiologically significant role, not only regulating in cell signals with second messenger but also being active in regulating transcription. Estrogen receptor (ER) which is a protein accepting estrogen not only play the role of a transcription factor combining with other genes to regulate their activity like other nuclear receptors but also performs external activities, combining with DNA, etc. G-protein coupled ER (GPER) that has been recently discovered exists as 7-membrane and has non-genomic (rapid) signaling. These functions, however, are not extensively addressed. This paper discusses the roles of GPER and its physiological mechanism.
The protective role of estrogen and estrogen receptors in cardiovascular disease and the controversial use of estrogen therapy

Andrea Iorga,Christine M. Cunningham,Shayan Moazeni,Gregoire Ruffenach,Soban Umar,Mansoureh Eghbali

DOI: https://doi.org/10.1186/s13293-017-0152-8

2017-10-24

Biology of Sex Differences

Abstract:Epidemiologic studies have previously suggested that premenopausal females have reduced incidence of cardiovascular disease (CVD) when compared to age-matched males, and the incidence and severity of CVD increases postmenopause. The lower incidence of cardiovascular disease in women during reproductive age is attributed at least in part to estrogen (E2). E2 binds to the traditional E2 receptors (ERs), estrogen receptor alpha (ERα), and estrogen receptor beta (ERβ), as well as the more recently identified G-protein-coupled ER (GPR30), and can exert both genomic and non-genomic actions. This review summarizes the protective role of E2 and its receptors in the cardiovascular system and discusses its underlying mechanisms with an emphasis on oxidative stress, fibrosis, angiogenesis, and vascular function. This review also presents the sexual dimorphic role of ERs in modulating E2 action in cardiovascular disease. The controversies surrounding the clinical use of exogenous E2 as a therapeutic agent for cardiovascular disease in women due to the possible risks of thrombotic events, cancers, and arrhythmia are also discussed. Endogenous local E2 biosynthesis from the conversion of testosterone to E2 via aromatase enzyme offers a novel therapeutic paradigm. Targeting specific ERs in the cardiovascular system may result in novel and possibly safer therapeutic options for cardiovascular protection.

biology
Activation of G protein‐coupled estrogen receptor 1 (GPER) induced coronary vasodilation by activation of MLCP via cAMP/PKA pathway

Xuan Yu,Fen Li,Richard E. White,John N. Stallone,Cristine L. Heaps,Guichun Han

DOI: https://doi.org/10.1096/fasebj.27.1_supplement.1096.18

2013-04-01

The FASEB Journal

Abstract:Activation of GPER exerts a protective effect in hypertension and ischemia‐reperfusion models, and relaxes arteries in vitro. However, our understanding of the mechanisms of GPER‐mediated vascular regulation is far from completed. We have investigated whether GPER‐mediated relaxation of porcine coronary arteries involves cAMP/PKA signaling. In these vessels, the selective GPER agonist, G‐1, increased cAMP production in a concentration‐dependent manner. Myograph studies demonstrated that inhibiting the activity of adenylyl cyclase (AC) with100 μM SQ‐22538 inhibited 0.3–3 μM G‐1‐induced relaxation of coronary arteries preconstricted with 1 μM PGF2α. Activating AC with forskolin also induced a concentration‐dependent relaxation. Furthermore, G‐1‐induced coronary vasodilation was attenuated by inhibiting PKA with either 5μM Rp‐8‐CPT‐cAMPS or 5μM PKI. To determine downstream signals of the cAMP/PKA cascade, we measured myosin light chain phosphatase (MLCP) activity in these artery rings and cultured smooth muscle cells with Western blot by detecting phosphorylation of myosin‐targeting subunit protein‐1 (pMYPT‐1), the MLCP regulatory subunit. Treatment with G‐1 decreased pMYPT‐1induced by PGF2α. Both Rp‐8‐CPT‐cAMPS and PKI attenuated the decrease of pMYPT‐1 by G‐1. These findings demonstrate that cAMP/PKA signaling is involved in GPER‐mediated coronary vasodilation by activating MLCP.

cell biology,biochemistry & molecular biology,biology
17-β-estradiol and phytoestrogens elicit NO production and vasodilatation through PI3K, PKA and EGF receptors pathways, evidencing functional selectivity

Vicente Catalán-Salas,Pablo Sagredo,Williams Melgarejo,M.Verónica Donoso,J.Cesar Cárdenas,Armen Zakarian,Daniel Valdés,Claudio Acuña-Castillo,J. Pablo Huidobro-Toro

DOI: https://doi.org/10.1016/j.ejphar.2024.176636

IF: 5.195

2024-05-09

European Journal of Pharmacology

Abstract:Endothelial cells express multiple receptors mediating estrogen responses; including the G protein-coupled estrogen receptor (GPER). Past studies on nitric oxide (NO) production elicited by estrogens raised the question whether 17-β-estradiol (E2) and natural phytoestrogens activate equivalent mechanisms. We hypothesized that E2 and phytoestrogens elicit NO production via coupling to distinct intracellular pathways signalling. To this aim, perfusion of E2 and phytoestrogens to the precontracted rat mesentery bed examined vasorelaxation, while fluorescence microscopy on primary endothelial cells cultures quantified single cell NO production determined following 4-amino-5-methylamino-2',7'-difluoroescein diacetate (DAF) incubation. Daidzein (DAI) and genistein (GEN) induced rapid vasodilatation associated to NO production. Multiple estrogen receptor activity was inferred based on the reduction of DAF-NO signals; G-36 (GPER antagonist) reduced 75 % of all estrogen responses, while fulvestrant (selective nuclear receptor antagonist) reduced significantly more the phytoestrogens responses than E2. The joint application of both antagonists abolished the E2 response but not the phytoestrogen-induced DAF-NO signals. Wortmannin or LY-294002 (PI3K inhibitors), reduced by 90% the E2-evoked signal while altering significantly less the DAI-induced response. In contrast, H-89 (PKA inhibitor), elicited a 23% reduction of the E2-induced signal while blocking 80% of the DAI-induced response. Desmethylxestospongin-B (IP3 receptor antagonist), decreased to equal extent the E2 or the DAI-induced signal. Epidermal growth factor (EGF) induced NO production, cell treatment with AG-1478, an EGF receptor kinase inhibitor reduced 90% DAI-induced response while only 53% the E2-induced signals; highlighting GPER induced EGF receptor trans-modulation. Receptor functional selectivity may explain distinct signalling pathways mediated by E2 and phytoestrogens.

pharmacology & pharmacy
Toward a Theory of Process

S. Wolf

DOI: https://doi.org/10.1111/j.1748-720X.1992.tb01204.x

1992-12-01

Law Medicine and Health Care

Abstract:This article starts by finding a lack of procedural ethics in the usual debates over the functioning of ethics committees and the proper relationship of ethics committees and the courts, and traces this lack to the absence of a theory of process and process values. I then show why ethics commmittees are an excellent place to start in working on process. I therefore turn to the task of developing process values, and specifically a notion of patient-centered process. Here I recommend both process values commanded by our underlying substantive values, and further independent process values. I specifically suggest that surfacing problems of gender, racial, and economic bias make certain processes ethically mandatory. Having thus indicated what the needed process values might look like, I sketch their considerable theoretical potential. I return to the particular problem of ethics committees and the courts, and use my notion of patient-centered process to derive an answer to the question of how the two entities should interrelate. Finally, I step back to suggest where we might go from here in developing a theory of process.
Prostaglandin E2 Mediates Up-regulation of ERRα Expression with BPH-1 Condition Medium in Prostatic Stromal Cells

苗琳,石建党,周颖,杜小玲,吴荃,王克明,张琚

DOI: https://doi.org/10.3969/j.issn.1007-7626.2008.08.009

2008-01-01

Abstract:Estrogen receptor-related receptor α(ERRα)is an orphan nuclear hormone receptor that shares significant homology with the estrogen receptors(ERs)and directly or indirectly modulates estrogen pathways ,which play important roles in pathogenesis of benign prostatic hyperplasia (BPH). To study the effects of prostatic epithelial cell paracrine on the ERRα expression in prostatic stromal cells (PrSCs), conditioned medium (CM) of BPH-1 (a benign prostate hyperplasia epithelial cell line) and DU-145 (a prostate cancer cell line) were collected and used to treat prostatic stromal cells. The expression of ERRα in PrSCs was determined by real-time RT-PCR and Western blotting in BPH-1 and DU-145, and the expressions of cyclooxygenase-2 (COX-2, prostaglandin synthase 2) and prostaglandin E2 (PGE2) were also examined by real-time RT-PCR and ELISA. The CM of BPH-1 treated with NS-398 (a specific inhibitor of COX-2) was collected to analyze its effects on the ERRα expression. The results demonstrated that the CM from BPH-1, but not from DU-145, stimulated the expression of ERRα in PrSCs, which could be blocked by pretreat the CM producing cells with NS-398. The level of COX-2 mRNA was significantly higher in BPH-1 than DU-145, which correlated to the PGE2 secretion accordingly. The concentration of PGE2 in BPH-1 CM was reduced by NS-398, and PGE2 alone could stimulate ERRα expression in PrSCs. Our data suggested that BPH-1 CM could induce the ERRα expression by increasing the paracrine of PGE2, and promote the estrogen effect mediated by ERRα in PrSCs.
Estrogen Receptor Functions and Pathways at the Vascular Immune Interface

Aida Dama,Chiara Baggio,Carlotta Boscaro,Mattia Albiero,Andrea Cignarella

DOI: https://doi.org/10.3390/ijms22084254

2021-04-20

Abstract:Estrogen receptor (ER) activity mediates multiple physiological processes in the cardiovascular system. ERα and ERβ are ligand-activated transcription factors of the nuclear hormone receptor superfamily, while the G protein-coupled estrogen receptor (GPER) mediates estrogenic signals by modulating non-nuclear second messengers, including activation of the MAP kinase signaling cascade. Membrane localizations of ERs are generally associated with rapid, non-genomic effects while nuclear localizations are associated with nuclear activities/transcriptional modulation of target genes. Gender dependence of endothelial biology, either through the action of sex hormones or sex chromosome-related factors, is becoming increasingly evident. Accordingly, cardiometabolic risk increases as women transition to menopause. Estrogen pathways control angiogenesis progression through complex mechanisms. The classic ERs have been acknowledged to function in mediating estrogen effects on glucose metabolism, but 17β-estradiol also rapidly promotes endothelial glycolysis by increasing glucose transporter 1 (GLUT1) and 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 (PFKFB3) levels through GPER-dependent mechanisms. Estrogens alter monocyte and macrophage phenotype(s), and induce effects on other estrogen-responsive cell lineages (e.g., secretion of cytokines/chemokines/growth factors) that impact macrophage function. The pharmacological modulation of ERs for therapeutic purposes, however, is particularly challenging due to the lack of ER subtype selectivity of currently used agents. Identifying the determinants of biological responses to estrogenic agents at the vascular immune interface and developing targeted pharmacological interventions may result in novel improved therapeutic solutions.
Does GPER Really Function as a G Protein-Coupled Estrogen Receptor in vivo?

Jing Luo,Dongmin Liu

DOI: https://doi.org/10.3389/fendo.2020.00148

2020-03-31

Abstract:Estrogen can elicit pleiotropic cellular responses via a diversity of estrogen receptors (ERs)-mediated genomic and rapid non-genomic mechanisms. Unlike the genomic responses, where the classical nuclear ERα and ERβ act as transcriptional factors following estrogen binding to regulate gene transcription in estrogen target tissues, the non-genomic cellular responses to estrogen are believed to start at the plasma membrane, leading to rapid activation of second messengers-triggered cytoplasmic signal transduction cascades. The recently acknowledged ER, GPR30 or GPER, was discovered in human breast cancer cells two decades ago and subsequently in many other cells. Since its discovery, it has been claimed that estrogen, ER antagonist fulvestrant, as well as some estrogenic compounds can directly bind to GPER, and therefore initiate the non-genomic cellular responses. Various recently developed genetic tools as well as chemical ligands greatly facilitated research aimed at determining the physiological roles of GPER in different tissues. However, there is still lack of evidence that GPER plays a significant role in mediating endogenous estrogen action in vivo. This review summarizes current knowledge about GPER, including its tissue expression and cellular localization, with emphasis on the research findings elucidating its role in health and disease. Understanding the role of GPER in estrogen signaling will provide opportunities for the development of new therapeutic strategies to strengthen the benefits of estrogen while limiting the potential side effects.
Sex differences in the participation of endothelial mediators and signaling pathways involved in the vasodilator effect of a selective GPER agonist in resistance arteries of gonadectomized Wistar rats

Pollyana Peixoto,Ildernandes Vieira-Alves,Gisele Kruger Couto,Virgínia Soares Lemos,Luciana Venturini Rossoni,Nazaré Souza Bissoli,Roger Lyrio Dos Santos

DOI: https://doi.org/10.1016/j.lfs.2022.120917

2022-11-01

Abstract:Aim: Endothelial mechanisms underlying the vascular effects of estrogen modulated by the G protein-coupled estrogen receptor (GPER) are not well understood, especially in gonadal sex hormone deprivation. Thus, we investigated vascular function and endothelial signaling pathways involved in the selective activation of GPER in resistance arteries of gonadectomized rats. Methods: Gonadectomy was performed in Wistar rats of both sexes. After 21 days, the animals were euthanized. Concentration-response curves were obtained by cumulative additions of G-1 in third-order mesenteric arteries. The vasodilatory effects of G-1 were evaluated before and after endothelium removal or incubation with pharmacological inhibitors. Tissue protein expression was measured by western blotting. Assays with 4-amino-5-methylamino-2',7'-difluorofluorescein diacetate (DAF-FM) and 2',7' dichlorodihydrofluorescein-diacetate (H2DCF-DA) were performed in the arteries investigated. Immunolocalization was assessed by immunofluorescence. Results: G-1 induced partially endothelium-dependent relaxation in both sexes. The three isoforms of the enzyme nitric oxide synthase contributed to the production and release of nitric oxide in both gonadectomized groups, but the role of inducible nitric oxide synthase is more expressive in males. The mechanistic pathway by which endothelial nitric oxide synthase is phosphorylated appears to differ between sexes, with the rapid signaling pathway phosphatidylinositol-3-kinase/protein kinase B/endothelial nitric oxide synthase (PI3k-Akt-eNOS) being identified for males and mitogen-activated protein kinase/extracellular signal-regulated kinase/endothelial nitric oxide synthase (MEK-ERK-eNOS) for females. The contribution of hydrogen peroxide as an endothelial relaxation mediator seems to be greater in females. Conclusion: These results provide new insights into the effects of estrogen-induced responses via GPER on vascular function in gonadal sex hormone deprivation.
Structural analysis of unstable intermediate and stable forms of recombinant fowlpox virus.

K. Nazerian,S. Dhawale

DOI: https://doi.org/10.1099/0022-1317-72-11-2791

1991-11-01

Journal of General Virology

Abstract:The stability and structure of the products of recombination in a fowlpox virus (FPV) system using the thymidine kinase (TK) gene as the insertion site were examined. A 4.6 kb chimeric DNA fragment from the pUV1 expression vector, containing the bacterial lacZ gene and the vaccinia virus P7.5 promoter, was ligated into the XbaI site of the FPV TK gene. The resulting vector, pFTKlacZb, was transfected into chicken embryo fibroblast cultures infected with FPV at an m.o.i. of 0.1. Recombinants were screened for the expression of beta-galactosidase. Five recombinants were isolated and plaque-purified to 80 to 90% for expression of beta-glucosidase. Serial cell culture passage of the recombinants led to the gradual reappearance of the non-recombinant parental phenotype. Southern hybridization analysis of EcoRI fragments from all five recombinants indicated that a single cross-over homologous recombination had occurred between either the 5' or the 3' end fragments of the TK gene, generating unstable intermediate recombinants incorporating the entire pFTKlacZb vector. Secondary intermolecular or intramolecular recombination of intergenic repetitive sequences within the intermediate recombinants appears to have resulted in frequent regeneration of the parental genotype and an infrequent generation of more stable recombinants. A method was developed to select stable recombinants by passage of the intermediate recombinants in chicken embryo fibroblast cultures treated with 5-bromo-2'-deoxyuridine.
G Protein-Coupled Estrogen Receptor, GPER1, Offers a Novel Target for the Treatment of Digestive Diseases

Chelsea DeLeon,David Q.-H. Wang,Christopher K. Arnatt

DOI: https://doi.org/10.3389/fendo.2020.578536

IF: 6.055

2020-11-12

Frontiers in Endocrinology

Abstract:There are gender differences between men and women in many physiological functions and diseases, which indicates that female sex hormones may be important. Traditionally, estrogen exerts its biological activities by activating two classical nuclear estrogen receptors, ESR1 and ESR2. However, the roles of estrogen in the regulation of physiological functions and the pathogenesis of diseases become more complicated with the identification of the G protein-coupled estrogen receptor (GPER1). Although many GPER1-specific ligands have been developed, the therapeutic mechanisms of exclusively targeting GPER1 are not yet well understood. Translational applications and clinical trial efforts for the identified GPER1 ligands have been focused primarily on the reproductive, cardiovascular, nervous, endocrine, and immune systems. More recently, research found that GPER1 may play an important role in regulating the digestive system. Cholesterol gallstone disease, a major biliary disease, has a higher prevalence in women than in men worldwide. Emerging evidence implies that GPER1 could play an important role, independent of the classical ESR1, in the pathophysiology of cholesterol gallstones in women. This review discusses the complex signaling pathways of three estrogen receptors, highlights the development of GPER1-specific ligands, and summarizes the latest advances in the role of GPER1 in the pathogenesis of gallstone formation.

endocrinology & metabolism
Cold Hands or Feet: Is It Raynaud's or Not?

Daniella Kadian-Dodov

DOI: https://doi.org/10.1016/j.mcna.2023.04.005

Abstract:Raynaud's phenomenon is an exaggerated response to cold stimuli that may be primary or secondary. The diagnosis relies on patient history and physical examination to distinguish RP from other vasomotor dysfunction (e.g. acrocyanosis, pernio, small fiber neuropathy with vasomotor symptoms, and complex regional pain syndrome). Achenbach syndrome, or spontaneous venous hemorrhage, may also be mistaken for RP but is a self-limiting phenomenon. Laboratory evaluation and vascular diagnostic testing may identify SRP causes. Regardless of etiology, treatment includes warming with trigger avoidance, and consideration of vasodilators (eg. calcium channel, alpha-1 blockers). SRP with digital ulceration may require PDE5i, endothelin-1 receptor blockers, and prostanoids. Refractory cases may require pneumatic arterial pumps, botulinum toxin administration, or surgical sympathectomy.
Oral application of insulin encapsulated liposomes.

N. Das,M. Basu,M. Das

1988-06-01

Abstract:125Iodine labelled insulin encapsulated liposomes were introduced orally to rats. After different intervals of feeding, blood from the portal vein and heart was collected. The plasma was passed through a Sepharose 2B column to establish the presence of liposomes or intact hormone. Liposomal and hormonal fractions from the column loaded with plasma from the portal vain contained radioactivity. It was found that approx. 60% of the loaded radioactivity was associated with the liposomes whereas 20% of the loaded count was found with the hormonal fractions. It is noted that undegraded protein is not detected in portal plasma from rats fed with free insulin. When plasma from the heart of rats fed with liposomal insulin was passed through Sepharose 2B column, neither liposomes nor insulin was detected.
Determination of molecular pathways and gene ontology of genes associated with Raynaud's phenomenon

Gözde Öztan

DOI: https://doi.org/10.1515/tjb-2023-0197

2024-06-15

Turkish Journal of Biochemistry

Abstract:Objectives Raynaud's phenomenon (RF) is a disease that causes discoloration of the fingers. The purpose of this study is to identify the molecular pathways in which genes related to RP illness are involved, as well as uncover the biological processes and molecular functions connected with those genes via the use of gene ontology (GO) analysis. Methods Genes associated with RP in the MalaCards Human Diseases database were detected. Twenty genes obtained from the MalaCards Human Diseases database were included in the study for gene ontology analysis via the STRING database. Accordingly, possible interactions between 20 genes were determined through STRING and network enrichment was performed. Results A significant enrichment by gene ontology enrichment analysis was detected in a subset of genes involved in biological processes including cellular response to luteinizing hormone stimulus, negative regulation of fibrinolysis, negative regulation of smooth muscle cell apoptotic process, plasminogen activation, cellular response to follicle-stimulating hormone stimulus. The assay for molecular function determined enrichment of a subset of genes in chemoattractant activity, growth factor activity, heparin binding, sulfur compound binding, growth factor receptor binding. Through the use of KEGG pathways, we were able to identify many molecular processes that contribute to RP, including the AGE-RAGE signaling pathway in diabetic complications, complement and coagulation cascades, fluid shear stress, atherosclerosis. Conclusions Some individuals may have a genetic predisposition to the onset of Raynaud's phenomenon. Our data showed that it is associated with genes involved in vascular damage and fibrosis, especially in RP. Therefore, we can include RP disease in the group of vascular diseases.

biochemistry & molecular biology

PREDISSOCIATION DYNAMICS OF HCP: ROTATIONAL DISTRIBUTION OF PRODUCT CP RADICAL

GPER Acts Through the cAMP/Epac/JNK/AP-1 Pathway to Induce Transcription of Alpha 2C Adrenoceptor in Human Microvascular Smooth Muscle Cells

The Role of G Protein-Coupled Estrogen Receptor (GPER) in Vascular Pathology and Physiology

Role of GPER in estrogen-dependent nitric oxide formation and vasodilation

Ligand recognition, unconventional activation, and G protein coupling of the prostaglandin E<sub>2</sub> receptor EP2 subtype

Activation of G Protein-Coupled Estrogen Receptor (GPER) Negatively Modulates Cardiac Excitation–Contraction Coupling (ECC) through the PI3K/NOS/NO Pathway

17β-Estradiol inhibits oleic acid-induced rat VSMC Proliferation and migration by restoring PGC-1α expression

G-protein Coupled Estrogen Receptor (GPER/GPR30) and Women's Health

The protective role of estrogen and estrogen receptors in cardiovascular disease and the controversial use of estrogen therapy

Activation of G protein‐coupled estrogen receptor 1 (GPER) induced coronary vasodilation by activation of MLCP via cAMP/PKA pathway

17-β-estradiol and phytoestrogens elicit NO production and vasodilatation through PI3K, PKA and EGF receptors pathways, evidencing functional selectivity

Toward a Theory of Process

Prostaglandin E2 Mediates Up-regulation of ERRα Expression with BPH-1 Condition Medium in Prostatic Stromal Cells

Estrogen Receptor Functions and Pathways at the Vascular Immune Interface

Does GPER Really Function as a G Protein-Coupled Estrogen Receptor in vivo?

Sex differences in the participation of endothelial mediators and signaling pathways involved in the vasodilator effect of a selective GPER agonist in resistance arteries of gonadectomized Wistar rats

Structural analysis of unstable intermediate and stable forms of recombinant fowlpox virus.

G Protein-Coupled Estrogen Receptor, GPER1, Offers a Novel Target for the Treatment of Digestive Diseases

Cold Hands or Feet: Is It Raynaud's or Not?

Oral application of insulin encapsulated liposomes.

Determination of molecular pathways and gene ontology of genes associated with Raynaud's phenomenon